Study of a new form of paclitaxel for advanced breast cancer
Part of Cancer clinical trials.
This study tests an experimental version of the chemotherapy drug paclitaxel for people with advanced breast cancer. It may help shrink tumors and slow the cancer's growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer that is advanced and can be treated with paclitaxel alone.
- You have at least one tumor that can be measured on a scan.
- You are 18 years or older.
- You are physically capable of daily activities (ECOG 0 or 1).
- Your major organs (like bone marrow, liver, kidneys) are working well enough.
- You are willing to use reliable birth control if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of low-dose oral paclitaxel (a chemotherapy pill taken regularly) plus immunotherapy to treat advanced breast cancer that doesn't have high levels of HER2 protein. The goal is to slow or shrink tumors while managing side effects better than traditional high-dose chemotherapy.
This trial compares a new chemotherapy drug (called HB1801) to the standard drug docetaxel (Taxotere) for advanced breast cancer. The goal is to see if the new drug works as well and is as safe as the standard one. If you qualify, you would receive one of these treatments, which may help shrink or slow the growth of your cancer.
This study checks if a generic version of paclitaxel protein-bound particles works the same as the brand-name drug in people with breast cancer. It's for patients whose cancer has spread or returned, and who might benefit from this medicine alone.
This trial tests paclitaxel given as tiny micelle particles for people whose cancer (pancreatic, bile duct, lung, stomach, esophagus, or breast) stopped responding to taxane chemotherapy or did not shrink. The goal is to see if this treatment can help when standard taxanes no longer work.
This trial tests a new form of the chemotherapy drug paclitaxel (called polymeric micellar paclitaxel) for people with pancreatic cancer that has spread to other parts of the body (metastatic). It's for those who haven't had any prior treatment for their metastatic cancer, and aims to see if this drug can help control the cancer.
This study tests whether a new version of paclitaxel (albumin-bound) works the same as the approved version in people with breast cancer. It's for patients whose cancer has spread or returned after other treatments, or those for whom this drug is recommended by treatment guidelines.
Hear when a new Advanced Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.